Trends in Use and Perceptions About Triplet Chemotherapy Plus Bevacizumab for Metastatic Colorectal Cancer

S.C. van Nassau, M.J. Bond, I. Scheerman, J. van Breeschoten, R. Kessels, L.B. Valkenburg-van Iersel, H.M. Verheul, T.E. Buffart, L.J. Mekenkamp, V.E. Lemmens, M. Koopman, G.M. Bol*, EXCITE (From Clinical Trial to Bedside: Triplet Chemotherapy in Metastatic Colorectal Cancer) Study Group

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'Trends in Use and Perceptions About Triplet Chemotherapy Plus Bevacizumab for Metastatic Colorectal Cancer'. Together they form a unique fingerprint.

Keyphrases

INIS

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science